Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The symptoms associated with COPD include overproduction of mucus and inflammation in the
lungs. Overproduction of mucus results in impaired lung function and it encourages bacterial
growth and associated COPD exacerbations. Therefore, a treatment that inhibits mucus
overproduction or blocks inflammation could benefit COPD patients. The drug under evaluation
in this study, BIO-11006 Inhalation Solution, is a new drug that may inhibit overproduction
of mucus and may have important anti-inflammatory properties.